Serum soluble interleukin-2 receptor in eosinophilia

Area of Science:

• Immunology
• Hematology
• Clinical Medicine

Background:

• Eosinophilia is associated with various conditions, including allergic diseases, neoplasms, and collagen diseases.
• Soluble interleukin-2 receptor (sIL-2R) is a marker of immune system activation.
• The clinical significance of sIL-2R in eosinophilia requires further elucidation.

Purpose of the Study:

• To investigate the relationship between sIL-2R levels and clinical characteristics in patients with eosinophilia.
• To determine if sIL-2R can differentiate between allergic and non-allergic causes of eosinophilia.
• To assess the utility of sIL-2R as a marker for disease severity in eosinophilic disorders.

Main Methods:

• Retrospective analysis of 60 patients with eosinophilia.
• Measurement of serum sIL-2R and IgE levels.
• Correlation analysis between sIL-2R levels, eosinophil counts, IgE levels, and underlying diseases.

Main Results:

• Thirty-eight out of 60 patients had elevated sIL-2R levels (>800 U/ml).
• In patients with high sIL-2R, levels correlated with eosinophil count but not IgE; underlying diseases included neoplasms and collagen diseases.
• In patients with low sIL-2R, levels correlated with IgE but not eosinophil count.

Conclusions:

• Elevated sIL-2R in eosinophilia patients suggests underlying non-allergic diseases and potentially greater disease severity.
• sIL-2R may serve as a valuable biomarker for assessing the etiology and severity of eosinophilic conditions.
• Distinguishing between high and low sIL-2R levels aids in identifying potential underlying pathologies in eosinophilia.